首页> 外文期刊>BioMed research international >Efficacy of Sublingual Immunotherapy with Dermatophagoides farinae Extract in Monosensitized and Polysensitized Patients with Allergic Rhinitis: Clinical Observation and Analysis
【24h】

Efficacy of Sublingual Immunotherapy with Dermatophagoides farinae Extract in Monosensitized and Polysensitized Patients with Allergic Rhinitis: Clinical Observation and Analysis

机译:舌下免疫疗法与皮肤病患者的皮肤病患者过敏性鼻炎患者的疗效:临床观察和分析

获取原文
获取原文并翻译 | 示例
           

摘要

Aim. To investigate differences in the efficacy of sublingual immunotherapy with Dermatophagoides farinae drops in monosensitized and polysensitized allergic rhinitis patients. Methods. The patients enrolled in the study were treated for more than one year by sublingual immunotherapy (SLIT) using Dermatophagoides farinae drops and were divided into a monosensitized group (n = 20) and a polysensitized group (n = 30). Total nasal symptom scores of patients before and after SLIT were analyzed to evaluate the curative effect. The phylogenetic tree of dust mite allergens as well as other allergens that were tested by skin prick test was constructed to help the analysis. Results. There was no significant difference in the efficacy of SLIT between dust mite monosensitized and polysensitized patients. Conclusions. Both dust mite monosensitized and polysensitized patients could be cured by SLIT using Dermatophagoides farinae drops. This study provides a reference for the selection of allergens to be used in immunotherapy for polysensitized AR patients.
机译:目的。探讨舌下免疫疗法与皮肤病菌滴在单敏化和聚胶液过敏性鼻炎患者中的疗效差异。方法。使用Dermatophagoides Farinae Drops的舌下免疫疗法(狭缝)将注册该研究的患者进行了一年以上,并分为单敏化基团(n = 20)和聚敏化基团(n = 30)。分析裂缝前后患者的总鼻症状评分评估疗效。构建了粉尘螨过敏原的系统发育树以及由皮肤刺试验测试的其他过敏原,以帮助分析。结果。粉尘螨单胶质和聚胶质患者之间的狭缝效果没有显着差异。结论。粉尘螨单抗体化和聚敏患者可以通过使用Dermatophagoides Farinae滴剂来固化。本研究为选择用于聚敏的AR患者的免疫疗法选择过敏原提供参考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号